Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney (Q46055734)

19 December 2017

title

Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney (English)

1 reference

19 December 2017

0 references

Talya Wolak

1

1 reference

19 December 2017

HyunJu Kim

2

1 reference

19 December 2017

Yuelan Ren

3

1 reference

19 December 2017

Jason Kim

4

1 reference

19 December 2017

Nosratola D Vaziri

5

1 reference

19 December 2017

Susanne B Nicholas

6

1 reference

19 December 2017

language of work or name

English

0 references

publication date

8 April 2009

1 reference

19 December 2017

published in

Kidney International

1 reference

19 December 2017

volume

76

1 reference

19 December 2017

issue

1

1 reference

19 December 2017

page(s)

32-43

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1038/ki.2009.90

exact match

0 references

cites work

Prevalence and characteristics of individuals with chronic kidney disease in a large health maintenance organization

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Angiotensin II upregulates toll-like receptor 4 on mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Renal and vascular hypertension-induced inflammation: role of angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

The nature and significance of osteopontin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Osteopontin expression and function: Role in bone remodeling.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Beneficial effects of CCR1 blockade on the progression of chronic renal allograft damage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Altered wound healing in mice lacking a functional osteopontin gene (spp1).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Phagocytosis induces superoxide formation and apoptosis in macrophages

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Evidence that fibroblasts derive from epithelium during tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Exaggerated Left Ventricular Dilation and Reduced Collagen Deposition After Myocardial Infarction in Mice Lacking Osteopontin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Identification of renox, an NAD(P)H oxidase in kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

NADPH oxidases in the kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Laser capture microdissection-microarray analysis of focal segmental glomerulosclerosis glomeruli

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Effect of FTY720 on chronic cyclosporine nephropathy in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Long-term aldosterone treatment induces decreased apical but increased basolateral expression of AQP2 in CCD of rat kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Macrophage infiltration and cellular proliferation in the non-ischemic kidney and heart following prolonged unilateral renal ischemia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in anti-thymocyte antibody-induced glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Angiotensin II: a regulator of inflammation during renal disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Tubular kidney injury molecule-1 in protein-overload nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.90

7 January 2021

Identifiers

DOI

10.1038/KI.2009.90

1 reference

19 December 2017

PubMed ID

19357716

1 reference

19 December 2017